Honourable Ministers, Excellencies, pricey colleagues and mates,
Good morning, good afternoon and good night to all Member States, and thanks for becoming a member of us as soon as once more.
Reported circumstances of COVID-19 have elevated practically 30% over the previous two weeks.
4 out of six of the WHO sub-regions noticed circumstances improve within the final week.
In Europe and America, BA.4 and BA.5 are driving waves. A brand new sub lineage of Omicron known as BA.2.75 has additionally been detected, which we’re following intently.
Compounding the problem are a variety of components:
First, testing has decreased dramatically in lots of international locations. This obscures the true image of an evolving virus and the true burden of COVID-19 illness globally.
It additionally signifies that therapies should not given early sufficient to stop severe sickness and loss of life.
Second, new therapies, particularly promising new oral antivirals, are nonetheless not reaching low- and low-middle revenue international locations, depriving entire populations that want them.
Third, because the virus evolves, vaccines safety – whereas nonetheless actually efficient at stopping severe illness and loss of life – does wane.
Lowering immunity underscores the significance of boosters, particularly for probably the most at-risk.
Fourth, every wave of the virus leaves extra individuals with a post-COVID situation, also known as long-COVID.
Well being methods are strained, and economies and societies are being disrupted.
Important steps to take embody:
One, vaccinate and enhance these at most threat. This consists of older individuals, individuals with continual diseases, the immunocompromised and well being staff.
Many of those teams stay unprotected in too many international locations.
Two, make new oral antivirals and different therapies accessible to all.
Working with World Fund and UNICEF, WHO has developed an allocation mechanism to assist international locations as antivirals change into accessible.
Nonetheless, our organizations are nonetheless attempting to finalize the phrases and circumstances for low- and middle-income international locations.
Yesterday I known as on Pfizer to work intently with us and with international locations to make sure its new oral antiviral is accessible far more shortly.
I’ll maintain you apprised of the end result within the coming weeks.
Third, is persons are in locations the place circumstances are on the rise, they need to use tried and examined public well being measures to mitigate threat, comparable to air flow, masks, bodily distancing, and if persons are sick, to remain dwelling.
Fourth, it’s essential to speed up analysis and improvement into subsequent era vaccines, assessments and coverings.
WHO is working with scientists and researchers around the globe to make this occur by the various networks working with the R&D Blueprint, and the Solidarity Trials for Vaccines and Therapeutics, to assist make scientific trials speedier and extra environment friendly.
We don’t know what the subsequent variant will likely be like. That’s the reason we have to develop the subsequent era of counter measures shortly.
Fifth, to strengthen the worldwide well being structure for well being emergency and response, each nationally and internationally.
We welcome the information in regards to the creation of the monetary middleman fund, which can concentrate on strengthening pandemic prevention, preparedness, and response capacities, with a concentrate on low- and middle-income international locations.
WHO and the World Financial institution will co-lead the fund.
In the meantime, the Intergovernmental Negotiating Physique continues its work on the brand new accord for pandemic prevention, preparedness and response. We hope all Member States have interaction on this course of.
On monkeypox, I proceed to be involved by the size and unfold of the virus.
Greater than 7,000 circumstances have been recorded in 60 international locations.
Testing stays a problem and it’s extremely possible that there are a big variety of circumstances not being picked up.
Europe is the present epicentre of the outbreak, recording greater than 80 % of circumstances globally.
In Africa, circumstances are additionally showing in international locations not beforehand affected, whereas international locations with expertise of monkeypox are discovering file ranges of an infection.
My groups are following the info intently. I plan to reconvene the Emergency Committee so they’re up to date on the present epidemiology and evolution of the outbreak, and implementation of counter measures.
I’ll carry them collectively in the course of the week of 18 July, or sooner if wanted.
WHO is working with international locations and vaccine producers to coordinate the sharing of vaccine, which is scarce and must be accessible to in danger individuals.
There’s a want to gather information on the efficacy and security of each vaccines and therapeutics for monkeypox and WHO helps coordinate analysis efforts to do that.
WHO can be working with civil society and the LGBTIQ+ group, particularly to interrupt the stigma across the virus and share info so individuals can shield themselves.
Lastly, in Syria, the humanitarian wants are at their highest stage because the battle began 11 years in the past.
WHO is working throughout the nation to supply lifesaving well being assist.
Within the northwest of the nation, some 4.4 million individuals, together with greater than 3.5 million girls and kids, want humanitarian help.
They depend upon cross-border entry for his or her healthcare, their vaccines and medicines.
We hope the Safety Council will discover settlement to protect the well being and welfare of this extremely susceptible inhabitants by renewing the decision to maintain a cross-border humanitarian hall open.
Immediately, we’ll be listening to an epidemiological replace on monkeypox from Assistant Director-Normal Dr Jaouad Mahjour and Dr Rosamund Lewis.
We are going to then hear an replace on progress by the ACT Accelerator Facilitation Council and the upcoming impartial analysis of ACT-A.
I’m delighted that we’ve Professor Olive Shisana of South Africa and Ambassador Dr John-Arne Røttingen of Norway with us, to supply this briefing.
As all the time, we’re grateful on your engagement with right now’s shows, and we stay up for your questions, feedback and steering.